三十余载扎根生态环境监测一线，用专业守护绿水青山。吉林省生态环境监测中心副主任、正高级工程 师张竹青，以一颗赤诚环保心诠释着生态环境守护者的责任与担当，荣获吉林省先进工作者称号。 从2005年松花江"双苯厂"爆炸到2010年特大洪水，张竹青始终冲锋在前，科学指挥近20次省级以上环境 应急监测。在松花江洪灾中，她连续9昼夜奋战一线，以精准数据为决策提供坚实支撑，被授予省级"抗 洪抢险环境应急先进个人"称号。 面对诸多荣誉，张竹青总说"功劳属于默默奉献的团队"。如今，她仍与同事们一道，以高度的使命感投 身污染防治攻坚战，用智慧与汗水持续绘就美丽吉林的生态画卷。 在科研转化领域，她同样成果丰硕。主持参与国家水专项及省级课题20余项，获吉林省科技进步二等 奖、自然科学学术成果二等奖；发表论文12篇（其中SCI收录3篇），参与制修订国家及地方行业标准7 项，为环境管理提供了有力的方法支撑。 自1991年从南京大学毕业投身环境监测事业以来，张竹青始终深耕专业领域。作为生态环境部"三五人 才"一流专家、国家级实验室评审专家，她精通法规与业务，在两次全国土壤污染调查中展现卓越创新 能力——引入国际先进分析方法，主持建立60余 ...

Core Viewpoint - The article highlights the significant contributions of Li Wenhui in the field of hepatitis B virus research and the establishment of the innovative pharmaceutical company Huahui Anjian, which is on the verge of launching a groundbreaking drug for hepatitis treatment. Group 1: Research Achievements - Li Wenhui discovered the hepatitis B virus receptor, a milestone that has transformed the understanding of hepatitis B infection mechanisms and drug development [8][25]. - The World Health Organization reported that viral hepatitis is the second leading cause of infectious disease deaths globally, with approximately 1.3 million deaths in 2022, 83% of which were due to hepatitis B [6][7]. - The receptor identified by Li's team, sodium-taurocholate co-transporting polypeptide (NTCP), was published in 2012 and is considered a pivotal discovery in hepatitis research [8][19]. Group 2: Company Development - Huahui Anjian, co-founded by Li Wenhui and his colleagues, has made significant progress in developing safer and more effective treatments for hepatitis B and D, with its leading drug, Libeweita, having its market application accepted by the National Medical Products Administration [18][19]. - The company emphasizes a culture of openness and high standards, ensuring that all team members are encouraged to engage in constructive criticism to foster innovation [18][19]. Group 3: Personal Insights and Philosophy - Li Wenhui believes that the essence of scientific research lies in the process of discovery rather than the accolades received, emphasizing the importance of exploration and problem-solving in science [11][12]. - He advocates for a research environment that allows for trial and error, which he credits as a key factor in the success of the Beijing Institute of Life Sciences [14][15].

Core Viewpoint - Domestic beauty brands are entering a new stage of scientific research competition, with Shiseido's revenue reaching 6.793 billion yuan in 2024, a year-on-year increase of 62.1%, and a net profit of 800 million yuan, up 74% [2][3] Group 1: Research and Development Initiatives - Shiseido has initiated a series of R&D advancements focusing on scientific transformation, communication, and system upgrades, paving a new path for domestic brands' R&D layout [3][5] - The establishment of the "Kanshu Transformation Medical Fund" in 2024 aims to provide financial support for promising research projects in hospitals and universities, accelerating the conversion of scientific achievements into clinical applications [5][7] - The fund plans to allocate millions in funding for the 2024-2025 period, collaborating with several hospitals to conduct clinical research on skin anti-aging and sensitive skin care [7][9] Group 2: Market Trends and Competitive Landscape - The peptide cosmetic raw material market in China reached 1.45 billion yuan in 2021 and is projected to grow to 2.32 billion yuan by 2025, with a compound annual growth rate of 12.5%, significantly outpacing the overall beauty industry growth [13] - The competition surrounding peptide ingredients has evolved into a comprehensive contest of "research" and "communication," necessitating brands to establish their unique peptide communication systems [14][18] Group 3: Brand Development and Consumer Engagement - Shiseido's recent marketing efforts, including a collaboration with influencer Li Jiaqi, highlight the brand's advancements in peptide research and its commitment to educating consumers about ingredient technology [15][16] - The brand's narrative emphasizes its journey from reliance on imported ingredients to achieving technological breakthroughs in peptide research, enhancing consumer recognition and confidence in domestic products [16][31] Group 4: Future Strategies and Innovations - Shiseido aims to build a scientific brand strategy driven by four core areas: technological insight, scientific technology, scientific products, and scientific communication [25][28] - The company is committed to creating a dual-driven innovation R&D system that integrates market needs and technological advancements, ensuring efficient operation and collaboration across disciplines [27][29]